Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression
- PMID: 18725407
- PMCID: PMC6550301
- DOI: 10.1177/0272989X08315251
Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression
Abstract
Background: Comparing the costs and health value associated with alternative quality improvement efforts is useful. This study employs expert panel methodology to elicit numerical estimates based on a 0 to 1 utility scale of the health benefit of usual treatment patterns for 2 medical conditions.
Method: The approach includes development of clinical profiles and derivation of treatment benefit estimates via the elicitation of utility ratings before and after treatment. Clinical profiles specified characteristics of patient groups, treatments to be rated, and their combinations. A panel of 13 asthma and depression experts made a series of utility ratings (before any new treatment, 1 or 3 mo later with no treatment, 1 or 3 mo after initiating various common treatments) for adult patient groups with depression or asthma. The panel convened to discuss discrepancies and subsequently made final ratings. Treatment benefit estimates were derived from the ratings made by the panelists after the panel meeting.
Results: The treatment benefit estimates had face validity and minimal variability, indicating considerable consensus among experts. Treatment benefit estimates ranged from -0.03 to 0.25 for depression and from -0.04 to 0.24 for asthma. There was minimal variation in the estimates for both conditions (the estimates' standard deviations ranged from 0.01 to 0.06). Comparisons of the treatment benefit estimates before and after the expert panel meeting indicated substantial convergence, and evidence suggests that the benefit estimates are comparable across the 2 health conditions.
Conclusion: Comparable estimates of treatment benefit for distinct health conditions can be obtained from experts using the expert panel methodology.
Figures
Similar articles
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Interventions to improve inhaler technique for people with asthma.Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD012286. doi: 10.1002/14651858.CD012286.pub2. Cochrane Database Syst Rev. 2017. PMID: 28288272 Free PMC article. Review.
-
Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.Ont Health Technol Assess Ser. 2019 Feb 19;19(6):1-199. eCollection 2019. Ont Health Technol Assess Ser. 2019. PMID: 30873251 Free PMC article.
-
Review of the NAEPP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines.J Manag Care Pharm. 2008 Jan-Feb;14(1):41-9. doi: 10.18553/jmcp.2008.14.1.41. J Manag Care Pharm. 2008. PMID: 18240881 Free PMC article. Review.
Cited by
-
Towards personalizing treatment for depression : developing treatment values markers.Patient. 2013;6(1):35-43. doi: 10.1007/s40271-013-0003-6. Patient. 2013. PMID: 23420133 Free PMC article.
-
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma.Clin Drug Investig. 2012 Apr 1;32(4):253-65. doi: 10.2165/11598940-000000000-00000. Clin Drug Investig. 2012. PMID: 22352412
-
Which fractures are most attributable to osteoporosis?J Clin Epidemiol. 2011 Jan;64(1):46-53. doi: 10.1016/j.jclinepi.2010.07.007. J Clin Epidemiol. 2011. PMID: 21130353 Free PMC article. Review.
References
-
- Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC): National Academy Press; 2001. - PubMed
-
- McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45. - PubMed
-
- Gold MR, Siegel JE, Russell LB, Winstein MC. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
-
- Gafni A, Birch S. Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc SciMed. 1995;40(6):767–76. - PubMed
-
- Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989;9(2):142–9. - PubMed
